The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.

It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, new research finds that this is not the case.

ADHD can interfere with your quality of life and disrupt your work schedule. We know how busy life can get, and sometimes, it ...

ADHD is associated with impulsivity, hyperactivity, and trouble with focus, but kids with ADHD may also struggle with motor ...

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Women are driving soaring use of ADHD medication, experts say. Researchers from the University of Oxford highlighted a 20-fold rise in use of drugs to manage the condition among w ...

ADHD medication presciptions have surged in the UK over the past decade. Women have driven the record numbers, research ...

Researchers conducted a scoping review of research investigating the effects of cannabinoids on ADHD. They concluded that further research is needed to clarify the therapeutic potential of ...

A major new scientific review brings reassuring news for expectant parents: using acetaminophen, commonly known as Tylenol, during pregnancy does not increase a child’s risk of autism, ADHD, or ...

There is no link between acetaminophen use in pregnancy and autism or ADHD risk for the offspring, a new gold-standard review ...